The current stock price of CYRX is 9.43 USD. In the past month the price decreased by -4.07%. In the past year, price increased by 38.47%.
ChartMill assigns a technical rating of 5 / 10 to CYRX. When comparing the yearly performance of all stocks, CYRX is one of the better performing stocks in the market, outperforming 84.52% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to CYRX. The financial health of CYRX is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months CYRX reported a non-GAAP Earnings per Share(EPS) of 1.17. The EPS increased by 157.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 31.31% | ||
| ROA | 7.69% | ||
| ROE | 11.61% | ||
| Debt/Equity | 0.36 |
15 analysts have analysed CYRX and the average price target is 13.49 USD. This implies a price increase of 43.02% is expected in the next year compared to the current price of 9.43.
For the next year, analysts expect an EPS growth of 222.58% and a revenue growth -23.65% for CYRX
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 22.97 | 214.189B | ||
| DHR | DANAHER CORP | 25.5 | 152.995B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 153.66 | 50.923B | ||
| A | AGILENT TECHNOLOGIES INC | 21.83 | 37.462B | ||
| IQV | IQVIA HOLDINGS INC | 15.58 | 34.702B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.65 | 27.987B | ||
| WAT | WATERS CORP | 26.22 | 22.559B | ||
| ILMN | ILLUMINA INC | 26.17 | 20.694B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 29.42 | 16.615B | ||
| MEDP | MEDPACE HOLDINGS INC | 33.82 | 16.016B |
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 1,090 full-time employees. The company went IPO on 2015-07-24. The firm supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The firm's segments include Life Sciences Services and Life Sciences Products. The firm's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
CRYOPORT INC
112 Westwood Place, Suite 350
Brentwood TENNESSEE 37027 US
CEO: Jerrell W. Shelton
Employees: 1090
Phone: 19492321900
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 1,090 full-time employees. The company went IPO on 2015-07-24. The firm supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The firm's segments include Life Sciences Services and Life Sciences Products. The firm's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
The current stock price of CYRX is 9.43 USD. The price decreased by -1.98% in the last trading session.
CYRX does not pay a dividend.
CYRX has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
15 analysts have analysed CYRX and the average price target is 13.49 USD. This implies a price increase of 43.02% is expected in the next year compared to the current price of 9.43.
The PE ratio for CRYOPORT INC (CYRX) is 8.06. This is based on the reported non-GAAP earnings per share of 1.17 and the current share price of 9.43 USD.
CRYOPORT INC (CYRX) has a market capitalization of 472.16M USD. This makes CYRX a Small Cap stock.